Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis

Selection of patients suffering from hepatocellular carcinoma (HCC) in cirrhosis for liver transplantation follows limits of number and diameter of tumor nodules. It has not been investigated whether there is a correlation of these parameters with vascular invasion. From 1989 to 2000, 1,188 liver transplantations were performed in 1,087 patients, including 120 patients (11%) with an HCC in cirrhosis. Selection criteria were a maximal diameter of up to 5 cm if the tumor appeared to be uninodular or of up to 3 cm in the case of 2 or 3 nodules. The postoperative mortality rate was 1.7%. One‐, 5‐, and 10‐year survival was 90%, 71%, and 60%, respectively. In 940 transplantation patients without an HCC, these rates were 93%, 87%, and 83% (P < .0001). Vascular invasion and histopathologic grading were identified as prognostic parameters by multivariate analysis. In a logistic regression analysis, histopathologic grading and maximal diameter showed a significant correlation with a vascular invasion. Analyzing tumors larger than 5 cm, i.e., tumors not fulfilling the selection criteria as a result of diagnostic inaccuracy or progression thereafter, the rates of vascular invasion were significantly (P < .01) lower in patients suffering from well‐differentiated tumors (25%) when compared with moderately and poorly differentiated tumors (100%). Liver transplantation is a safe and effective long‐term treatment for small HCC in cirrhosis. Tumor diameter and number of nodules in correlation with the histopathologic grading were predictive of a vascular invasion only in HCC larger than 5 cm.

[1]  M. Schwartz,et al.  Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation , 2000, American Journal of Gastroenterology.

[2]  M. Tachibana,et al.  Prognostic factors after hepatic resection for hepatocellular carcinoma associated with Child-Turcotte class B and C cirrhosis. , 1999, Annals of surgery.

[3]  T. Starzl,et al.  Should hepatomas be treated with hepatic resection or transplantation? , 1999, Cancer.

[4]  T. Babineau,et al.  Role of staging laparoscopy in the treatment of hepatic malignancy. , 1994, American journal of surgery.

[5]  B. Turner International Union Against Cancer (UICC) , 1999 .

[6]  K. Tanikawa,et al.  Increased expression of vascular endothelial growth factor is associated with tumor progression in hepatocellular carcinoma. , 1998, Human pathology.

[7]  J. Belghiti,et al.  Intrahepatic Recurrence After Resection of Hepatocellular Carcinoma Complicating Cirrhosis , 1991, Annals of surgery.

[8]  M. Kojiro,et al.  Expression of vascular endothelial growth factor in human hepatocellular carcinoma , 1998, Hepatology.

[9]  C. Lo,et al.  Laparoscopy and laparoscopic ultrasonography avoid exploratory laparotomy in patients with hepatocellular carcinoma. , 1998, Annals of surgery.

[10]  J. Bruel,et al.  [Needle-tract seeding after ultrasound-guided puncture of hepatocellular carcinoma. A study of 150 patients]. , 1999, Gastroenterologie clinique et biologique.

[11]  J. Bruix,et al.  Liver transplantation for small hepatocellular carcinoma: The tumor‐node‐metastasis classification does not have prognostic power , 1998, Hepatology.

[12]  C. Putnam,et al.  Iatrogenic Alterations of Immunologic Surveillance in Man and Their Influence on Malignancy , 1971, Transplantation reviews.

[13]  H. Miyake,et al.  Assessment of the biological malignancy of hepatocellular carcinoma: relationship to clinicopathological factors and prognosis. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[14]  T. Starzl,et al.  Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation , 1991, Cancer.

[15]  N. Kneteman,et al.  Review: Research Toward Safer Resection of the Cirrhotic Liver , 2000, HPB surgery : a world journal of hepatic, pancreatic and biliary surgery.

[16]  W. Bechstein,et al.  Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial. , 1995, Clinical transplantation.

[17]  J. Tang,et al.  Hepatitis viral status in patients undergoing liver resection for hepatocellular carcinoma , 1999, The British journal of surgery.

[18]  W. Bechstein,et al.  Comparison of FK506- and cyclosporine-based immunosuppression in primary orthotopic liver transplantation. A single center experience. , 1995, Transplantation.

[19]  U. Neumann,et al.  De novo malignancies after liver transplantation using tacrolimus‐based protocols or cyclosporine‐based quadruple immunosuppression with an interleukin‐2 receptor antibody or antithymocyte globulin , 1997, Cancer.

[20]  L. Wong,et al.  Needle‐tract implantation from hepatocellular cancer: Is needle biopsy of the liver always necessary? , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[21]  H. Kinoshita,et al.  Clinical significance of prior hepatitis B virus infection in patients with hepatitis C virus–related hepatocellular carcinoma , 1999, Cancer.

[22]  Michiie Sakamoto,et al.  Growth and spread of hepatocellular carcinoma: A review of 240 consecutive autopsy cases , 1990, Cancer.

[23]  O. Farges,et al.  Is surgery for large hepatocellular carcinoma justified? , 1999, Journal of hepatology.

[24]  V. Mazzaferro,et al.  Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. , 1996, The New England journal of medicine.

[25]  M. Schwartz,et al.  Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors , 1998, Cancer.

[26]  I. Hyodo,et al.  Circulating vascular endothelial growth factor (VEGF) is a possible tumor marker for metastasis in human hepatocellular carcinoma , 1998, Journal of Gastroenterology.

[27]  H. Bismuth,et al.  Liver Resection Versus Transplantation for Hepatocellular Carcinoma in Cirrhotic Patients , 1993, Annals of surgery.